PostoperativecomplicationsRR · people with breast and axillary surgery
Fibrin glue instillation under skin flaps showed no clear difference in postoperativecomplicationsRR compared with no‐fibrin (low certainty).
1 finding from 1 review
Length of hospital stay (theoretical) · people with breast and axillary surgery
1 finding from 1 review
Overall survival · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy may leads to higher overall survival compared with chemotherapy alone (low certainty).
1 finding from 1 review
Nausea and vomiting · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon showed no clear difference in adverse event (nausea/ vomiting) compared with observation alone (low certainty).
1 finding from 1 review
Progression‐free survival · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy may leads to higher progression‐free survival compared with chemotherapy alone (low certainty).
1 finding from 1 review
Adverse event (flu‐like symptoms) · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy showed no clear difference in adverse event (flu‐like symptoms) compared with chemotherapy alone (low certainty).
1 finding from 1 review
Adverse effect: fatigue · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy showed no clear difference in adverse event (fatigue) compared with chemotherapy alone (low certainty).
1 finding from 1 review
Neurotoxicity · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon + chemotherapy showed no clear difference in adverse event (neurotoxicity) compared with chemotherapy alone (low certainty).
1 finding from 1 review
Overall survival · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon showed no clear difference in overall survival compared with observation alone (low certainty).
1 finding from 1 review
Progression‐free survival · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon showed no clear difference in progression‐free survival compared with observation alone (low certainty).
1 finding from 1 review
Adverse event (flu‐like symptoms) · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon may leads to higher adverse event (flu‐like symptoms) compared with observation alone (low certainty).
1 finding from 1 review
Adverse effect: fatigue · Women with advanced (Stage II‐IV) epithelial ovarian cancer who have undergone surgery
Interferon may leads to higher adverse event (fatigue) compared with observation alone (low certainty).
1 finding from 1 review
All‐cause mortality · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).
1 finding from 1 review
All cardiovascular death · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in death from cardiovascular causes compared with placebo or no treatment (low certainty).
1 finding from 1 review
Non‐fatal MI · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in myocardial infarction (non‐fatal) compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Stroke/TIA (non‐fatal) · participants with improving outcomes during and after noncardiac vascular surgery.
Perioperative statins showed no clear difference in stroke/TIA (non‐fatal) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Participant‐reported outcomes－not measured · participants with improving outcomes during and after noncardiac vascular surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse muscle effects · participants with improving outcomes during and after noncardiac vascular surgery.
1 finding from 1 review
Intervention not reported
Surgical failure (intraocular pressure >21mmHg) ( · patients with glaucoma surgery
The intervention probably leads to lower surgical failure (intraocular pressure >21mmHg) ( (moderate certainty).
1 finding from 1 review
Intervention not reported
Intraocular pressure ( · patients with glaucoma surgery
1 finding from 1 review